Biomarcadores moleculares en sepsis: revisión sistemática
| datacite.rights | http://purl.org/coar/access_right/c_abf2 | spa |
| dc.contributor.author | Fruto Maldonado, Jennifer | |
| dc.contributor.author | Velasquez, Luz Adriana | |
| dc.date.accessioned | 2020-09-12T16:46:46Z | |
| dc.date.available | 2020-09-12T16:46:46Z | |
| dc.date.issued | 2018 | |
| dc.description.abstract | Antecedentes: La sepsis es una condición común que se asocia con una mortalidad inaceptablemente alta, para muchos de los que sobreviven, morbilidad a largo plazo. La Asamblea Mundial de la Salud y la OMS hicieron de la sepsis una prioridad mundial de salud en 2017 y han adoptado medidas para mejorar la prevención, el diagnóstico y el tratamiento, el uso de biomarcadores predictores de la evolución de sepsis al shock séptico y por ende la mortalidad alta que conlleva este último. Objetivos: Describir el estado del arte de los biomarcadores moleculares propuestos para el diagnóstico y pronóstico de sepsis, sepsis grave y choque séptico, mediante la revisión sistemática de bases de datos en el periodo de 2014-2018. Materiales y Métodos: Articulo de revisión en la que se analizaron los registros de los últimos 5 años (2014-2018) que se encontraban en las bases de datos: MEDLINE (NML) PubMed. Clasificados por año de publicación e incluyendo solo artículos de investigación y de revisión que evaluaran o trataran las Palabras clave: “Presepsin”, “Biomarcadores”, “Sepsis”, “Shock séptico”. Resultados: Para la revisión se tuvieron en cuenta 32 artículos caracterizados por ser publicados en el periodo comprendido entre 2014 y 2018, los cuales describieron aspectos teóricos de la Presipsina CD14 soluble en relación con otros biomarcadores moleculares existentes actualmente con valores diagnósticos para el desarrollo de sepsis y choque séptico. | spa |
| dc.description.abstract | Background: Sepsis is a common condition that is associated with unacceptably high mortality, for many of those who survive, long-term morbidity. The World Health Assembly and WHO made sepsis a global health priority in 2017 and have adopted measures to improve prevention, diagnosis and treatment, the use of predictive biomarkers of the progression from sepsis to septic shock and for hence the high mortality associated with the latter. Objective: To describe the state of the art of the molecular biomarkers proposed for the diagnosis and prognosis of sepsis, severe sepsis and septic shock, through the systematic review of databases in the period 2014-2018. Materials and Methods: Review article in which the records of the last 5 years (2014-2018) that were in the databases were analyzed: MEDLINE (NML) PubMed. Classified by year of publication and including only research and review articles that evaluate or address the Keywords: "Presepsin", "Biomarkers", "Sepsis", "Septic shock". Results: For the review, 32 articles characterized by being published in the period between 2014 and 2018 were taken into account, which described theoretical aspects of soluble CD14 Presipsin in relation to other currently existing molecular biomarkers with diagnostic values for the development of sepsis and shock septic. | eng |
| dc.format.mimetype | spa | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12442/6490 | |
| dc.language.iso | spa | spa |
| dc.publisher | Ediciones Universidad Simón Bolívar | spa |
| dc.publisher | Facultad de Ciencias de la Salud | spa |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess | spa |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.subject | Presepsin | eng |
| dc.subject | Soluble CD-14 | eng |
| dc.subject | Biomarkers | eng |
| dc.subject | Sepsis | eng |
| dc.subject | Septic Shock | eng |
| dc.title | Biomarcadores moleculares en sepsis: revisión sistemática | spa |
| dc.type.driver | info:eu-repo/semantics/bachelorThesis | spa |
| dc.type.spa | Trabajo de grado - pregrado | spa |
| dcterms.references | Ortiz G, Dueñas C, Rodríguez F, Barrera L, de La Rosa, Dennis R, et al. Epidemiology of sepsis in Colombian intensive care units. Biomedica. 2014;34(1):40-7. Doi.org/bwk3. | eng |
| dcterms.references | Singer M, Deutschman CS, Seymour Cw, Shankar-Hari M, Annane D.The third international consensus definitions for sepsis and septic shock. JAMA. 2016;315(8):801-10. Doi: 10.1001/jama.2016.0287. | eng |
| dcterms.references | Ana Hernando Holgado, Luis García de Guadiana, Ana Fernández-Carballido, Sepsis biomarkers. An Real Acad Farm. 2017;83 (2):175-187 ISSN 1697-4298. | eng |
| dcterms.references | Liu B, Chen Y-X, Yin Q, Zhao Y-Z.Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department. An Real Acad Farm Crit Care. 2017 ;83( 2):175-187. ISSN 1697-4298. | eng |
| dcterms.references | Alfredo Prado-Díaz, Andrés Castillo, Diana, Marcela Rojas. Marcadores moleculares en el diagnóstico y pronóstico de sepsis, sepsis grave y choque séptico Molecular markers in the diagnosis and prognosis of sepsis, severe sepsis and septic shock. Revista de la Facultad de Medicina 2017;65(1):145-155. Doi.org/10.15446/revfacmed.v65n1.53876. ISSN 0120-0011. | spa |
| dcterms.references | Miyata M, Sato N, Takahashi. The utility of the soluble CD14 subtype for diagnosis of sepsis, the examination of the simple diagnostic kit. J Iwate med Assoc. 2015;10(12):325–31. DOI 10.1371/journal.pone.0143971. | eng |
| dcterms.references | Pugni L, Pietrasanta C, Milani S, Vener C, Ronchi A, Falbo M. Presepsin (Soluble CD14 Subtype): Reference Ranges of a New Sepsis Marker in Term and Preterm | eng |
| dcterms.references | Mohamed El-Saied El-Shafie, Khaled M. Taema, Moataz M. El-Hallag, Mohamed A K. Role of presepsin compared to C-reactive protein in sepsis diagnosis and prognostication. The Egyptian Journal of Critical Care Medicine 2017: 5 (1): 1–12. Doi.org/10.1016/j.ejccm.2017.02.001. | eng |
| dcterms.references | C. Rey Galán. Biomarkers of severe bacterial infection: Do they help in clinical practice?. Anales de Pediatría (English Edition), 2016: 84( 5): 247-248. DOI: 10.1016/j.anpede.2016.03.001. | eng |
| dcterms.references | A.J.Jiménez, Francisco C González, Juan G Castillo. Utilidad de los biomarcadores de inflamación e infección en los servicios de urgencias. Enfermedades Infecciosas y Microbiología Clínica, Elsevier. 2014:32(3):177-190. Doi.org/10.1016/j.eimc.2013.01.005. | spa |
| dcterms.references | A Echeverri, J Naranjo-Escobar, Posso-Osorio, D Aguirre-Valencia, D Zambrano, GL Castan, JD Martınez. Neutrophil CD64 expression, procalcitonin and presepsin are useful to differentiate infections from flares in SLE patients with SIRS. Lupus. 2018:27(7):1130-1139. Doi: 10.1177/0961203318763740. | eng |
| dcterms.references | Kei Hayashida, Yutaka Kondo, Yoshitaka Hara, Morio Aihara,Kazuma Yamakawa. Head to-head comparison of procalcitonin and presepsin for the diagnosis of sepsis In critically ill adult patients: a protocol for a systematic review and meta-analysis. BMJ 2017;7(3):014305. Doi:10.1136/bmjopen-2016-014305. | eng |
| dcterms.references | Maurizio Cecconi, Laura Evans, Mitchell Levy, Andrew Rhodes. Sepsis and septic shock.The Lancet. 2018:392(7): 75–87 Doi.org/10.1016/ S0140-6736(18)30696-2. | eng |
| dcterms.references | László I, Trásy D, Molnár Z, Fazakas J. Sepsis: From pathophysiology to individualized patient care. J Immunol. 2015;2015:510436 Doi: 10.1155/2015/510436. | eng |
| dcterms.references | Malokooti M, Kelleher M, Wald E. Inmune dysregulation in sepsis. Clin Pediatr Emerg Med. 2014;15:163--8. Doi. org/10.1016/j.cpem.2014.04.002 | eng |
| dcterms.references | Bin Lu, Yan Zhang, Chen Li a, Chenyan Liua, Ying Yaoa, Minghuan Sub, Songtao Shou. The utility of presepsin in diagnosis and risk stratification for the emergency patients with sepsis. American Journal of Emergency Medicine 2018:36: 1341–1345 .Doi.org/10.1016/j.ajem.2017.12.038. | eng |
| dcterms.references | Derek C. Angus,Tom van der Poll. Severe Sepsis and Septic Shock. The New England Journal of Medicine 2013;369:840-51. DOI: 10.1056/NEJMra1208623. | eng |
| dcterms.references | Martín-Ramírez JF, Domínguez-Borgua A, Vázquez-Flores AD. Sepsis. Med Int Méx. 2014;30 (2):159-175. | spa |
| dcterms.references | Martin A.,B Andres, Garzón Diana, Cuervo Francisco, Jazmín P Millánc. Actualización en sepsis y choque séptico: nuevas definiciones y evaluación clínica. Acta Colombiana de Cuidado Intensivo. 2017;17(3):158-183. Doi.org/10.1016/j.acci.2017.03.001. | spa |
| dcterms.references | Sato M, Takahashi G, Shibata S, Onodera M, Suzuki Y, Inoue Y, et al. Clinical Performance of a New Soluble CD14- Subtype Immunochromatographic Test for Whole Blood Compared with Chemiluminescent Enzyme Immunoassay: Use of Quantitative Soluble CD14-Subtype Immunochromatographic Tests for the Diagnosis of Sepsis. PLoS ONE 2015:10(12): e0143971. Doi:10.1371/journal.pone.0143971. | eng |
| dcterms.references | García de Guadiana L, Esteban P, Viqueira M,Jiménez R, Hernando A,Ortín A et al. Diagnostic accuracy of presepsin (soluble CD14 subtype) for prediction of bacteremia in patients with systemic inflammatory response syndrome in the Emergency Department. Clin Biochem. 2014; 47: 505–8. | eng |
| dcterms.references | Kweon OJ, Choi JH, Park SK, Park AJ. Usefulness of presepsin (sCD14 subtype) measurements as a new marker for the diagnosis and prediction of disease severity of sepsis in the Korean population. J. Crit. Care. 2014; 29:965–70 | eng |
| dcterms.references | Ali FT, Ali MAM, Elnakeeb MM, Bendary HNM. Presepsin is an early monitoring biomarker for predicting clinical outcome in patients with sepsis. Clin Chim Acta. 2016; 460:93-101. https://doi.org/10.1016/j. cca.2016.06.030 PMID: 27353646. | eng |
| dcterms.references | Nanno S, Koh H, Katayama T, Hashiba M, Sato A, Makuuchi Y, et al. Plasma Levels of Presepsin (Soluble CD14-subtype) as a Novel Prognostic Marker for Hemophagocytic Syndrome in Hematological Malignancies. Intern Med. 2016; 55(16):2173±84. Doi.org/10.2169/internalmedicine.55.6524 PMID: 27522992. | eng |
| dcterms.references | Nagata T, Yasuda Y, Ando M, Abe T, Katsuno T, Kato S, et al. Clinical impact of kidney function on presepsin levels. PLoS One. 2015; 10(6):e0129159. Doi.org/10.1371/journal.pone.0129159 PMID:26030716. | eng |
| dcterms.references | Nakamura Y, Ishikura H, Nishida T, Kawano Y, Yuge R, Ichiki R, et al. Usefulness of presepsin in the diagnosis of sepsis in patients with or without acute kidney injury. BMC Anesthesiol. 2014; 14:88. Doi.org/10.1186/1471-2253-14-88 PMID: 25309126. | eng |
| dcterms.references | Yang HS, Hur M, Yi A, Kim H, Lee S, Soo-Nyung Kim. Prognostic value of presepsin in adult patients with sepsis: Systematic review and meta-analysis. PLoS One 2018 01;13(1). Doi.org/10.1371/journal.pone.0191486. | eng |
| dcterms.references | Poggi C, Bianconi T, Gozzini E, Generoso M, Dani C. Presepsin for the detection of late-onset sepsis in preterm newborns. Pediatrics 2015; 135: 68–75. Doi: 10.1542/peds.2014-1755 PMID: 25511124 | eng |
| dcterms.references | Milcent K, Faesch S, Gras - Le Guen C, Dubos F, Marc E. Use of procalcitonin Assays to Predict serious bacterial infection in young febrile Infants. JAMA Pediatric.2016.Jan;170(1):62-9. Doi: 10.1001/jamapediatrics.20153210 | eng |
| dcterms.references | Sevgen T. Basaranoglu, Eda Karadag-Oncel, Kubr Aykac, Yasemin Ozsurekci. Presepsin: A new marker of catheter related blood stream infections inpediatric patients. J Infect Chemother 2018:24(1):25:30. Doi.org/10.1016/j.jiac.2017.08.012. | eng |
| dcterms.references | Masson S, Caironi P, Spanuth E, Thomae R, Panigada M, Sangiorgi G. Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial. Crit Care . 2014;18(1): 3-9. Doi: 10.1186/cc13183. | eng |
| dcterms.references | Jing Zhang, MD, Zhi-De Hu, MM, Jia Song, MD, and Jiang Shao. Diagnostic Value of Presepsin for Sepsis A Systematic Review and Meta-Analysis. Medicine Baltimore. 2015:94(47):2158 ISSN: 0025-7974. DOI: 10.1097/MD.0000000000002158. | eng |
| oaire.version | info:eu-repo/semantics/acceptedVersion | spa |
| sb.programa | Medicina | spa |
| sb.sede | Sede Barranquilla | spa |